Literature DB >> 18585537

Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium.

Jesus Ramirez-Bermudez1, Angel Ruiz-Chow, Ivan Perez-Neri, Jose Luis Soto-Hernandez, Ricardo Flores-Hernandez, Francisco Nente, Sergio Montes, Camilo Rios.   

Abstract

OBJECTIVE: The aim of this study was to determine if cerebrospinal fluid (CSF) levels of homovanillic acid (HVA) are related to the clinical features of delirium in a group of patients with acute onset neurological illness.
METHODS: Fifty-one patients with probable acute brain infection were classified as delirious and nondelirious according to Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition (DSM-IV) and Delirium Rating Scale (DRS). CSF HVA concentration was analyzed by high-performance liquid chromatography.
RESULTS: Delirium was present in 60.8% of the total sample. HVA levels were not significantly different between delirious and nondelirious patients. Remarkably, patients with psychotic symptoms shown higher levels of CSF HVA as compared to nonpsychotic patient values. In addition, HVA levels were positively correlated to specific items of DRS such as delusions (r=0.463, P=.001), hallucinations (r=0.438, P=.001), cognitive dysfunction (r=0.286, P=.042) and fluctuation of symptoms (r=0.280, P=.046) in the total sample. Subanalyses excluding patients taking antipsychotic drugs revealed that HVA CSF levels were higher in those patients with delusions, and furthermore, the dopamine metabolite remained positively correlated to delusion subscale of DRS.
CONCLUSIONS: Our results suggest that psychotic symptoms in delirious patients may be related to increased dopamine neurotransmission, as reflected by increased CSF HVA concentration, providing direct evidence to support the dopaminergic theory of psychosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585537     DOI: 10.1016/j.genhosppsych.2008.01.007

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  10 in total

1.  Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls.

Authors:  Andrew Pearson; Annick de Vries; Scott D Middleton; Fiona Gillies; Timothy O White; Ian R Armstrong; Ruth Andrew; Jonathan R Seckl; Alasdair Mj MacLullich
Journal:  BMC Res Notes       Date:  2010-02-08

Review 2.  The interface between delirium and dementia in elderly adults.

Authors:  Tamara G Fong; Daniel Davis; Matthew E Growdon; Asha Albuquerque; Sharon K Inouye
Journal:  Lancet Neurol       Date:  2015-06-29       Impact factor: 44.182

3.  Imbalance between nitric oxide and dopamine may underly aggression in acute neurological patients.

Authors:  J Ramírez-Bermudez; I Perez-Neri; S Montes; M Ramirez-Abascal; F Nente; A Abundes-Corona; J L Soto-Hernandez; C Rios
Journal:  Neurochem Res       Date:  2010-08-01       Impact factor: 3.996

4.  Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.

Authors:  Yen F Tai; Rosa Hoshi; Catherine M Brignell; Lisa Cohen; David J Brooks; H Valerie Curran; Paola Piccini
Journal:  Neuropsychopharmacology       Date:  2010-12-15       Impact factor: 7.853

5.  Delirium in elderly people: a review.

Authors:  Sónia Martins; Lia Fernandes
Journal:  Front Neurol       Date:  2012-06-19       Impact factor: 4.003

6.  Increased CSF levels of aromatic amino acids in hip fracture patients with delirium suggests higher monoaminergic activity.

Authors:  Leiv Otto Watne; Ane-Victoria Idland; Durk Fekkes; Johan Raeder; Frede Frihagen; Anette Hylen Ranhoff; Farrukh Abbas Chaudhry; Knut Engedal; Torgeir Bruun Wyller; Bjørnar Hassel
Journal:  BMC Geriatr       Date:  2016-08-02       Impact factor: 3.921

7.  Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion.

Authors:  Tanja Veselinović; Ingo Vernaleken; Paul Cumming; Uwe Henning; Lina Winkler; Peter Kaleta; Michael Paulzen; Christian Luckhaus; Gerhard Gründer
Journal:  Neuropsychiatr Dis Treat       Date:  2018-04-27       Impact factor: 2.570

Review 8.  New horizons in the pathogenesis, assessment and management of delirium.

Authors:  Alasdair M J Maclullich; Atul Anand; Daniel H J Davis; Thomas Jackson; Amanda J Barugh; Roanna J Hall; Karen J Ferguson; David J Meagher; Colm Cunningham
Journal:  Age Ageing       Date:  2013-09-25       Impact factor: 10.668

9.  Disturbed Serotonergic Neurotransmission and Oxidative Stress in Elderly Patients with Delirium.

Authors:  Angelique Egberts; Durk Fekkes; Eline H A Wijnbeld; Milly A van der Ploeg; Jan L C M van Saase; Gijsbertus Ziere; Tischa J M van der Cammen; Francesco U S Mattace-Raso
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-12-03

Review 10.  Delusion and Delirium in Neurodegenerative Disorders: An Overlooked Relationship?

Authors:  Daniele Urso; Valentina Gnoni; Marco Filardi; Giancarlo Logroscino
Journal:  Front Psychiatry       Date:  2022-01-18       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.